DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,000 | -70.6% | 991 | 0.0% | 0.00% | -77.8% |
| Q3 2021 | $34,000 | -5.6% | 991 | 0.0% | 0.01% | -64.0% |
| Q2 2021 | $36,000 | -18.2% | 991 | 0.0% | 0.02% | -21.9% |
| Q1 2021 | $44,000 | -22.8% | 991 | 0.0% | 0.03% | -28.9% |
| Q4 2020 | $57,000 | +11.8% | 991 | 0.0% | 0.04% | +4.7% |
| Q3 2020 | $51,000 | -13.6% | 991 | 0.0% | 0.04% | -23.2% |
| Q2 2020 | $59,000 | +43.9% | 991 | 0.0% | 0.06% | +24.4% |
| Q1 2020 | $41,000 | -33.9% | 991 | 0.0% | 0.04% | -18.2% |
| Q4 2019 | $62,000 | +82.4% | 991 | 0.0% | 0.06% | +71.9% |
| Q3 2019 | $34,000 | +54.5% | 991 | 0.0% | 0.03% | +60.0% |
| Q2 2019 | $22,000 | -4.3% | 991 | 0.0% | 0.02% | +53.8% |
| Q1 2019 | $23,000 | +9.5% | 991 | 0.0% | 0.01% | +8.3% |
| Q4 2018 | $21,000 | -44.7% | 991 | 0.0% | 0.01% | -29.4% |
| Q3 2018 | $38,000 | -2.6% | 991 | 0.0% | 0.02% | -5.6% |
| Q2 2018 | $39,000 | – | 991 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |